Vyome Holdings, Inc. (HIND)

NASDAQ: HIND · USD

$1.66

-0.04 (-2.4%)· Recorded snapshot

Market cap	11.7M
Revenue (ttm)	129.7K
Net income (ttm)	-11.3M
EPS (ttm)	-$1.61
Shares out	7M
Volume	7,157

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 129.7K
Net income (ttm): -11.3M
EPS (ttm): -$1.61
Market cap: 11.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-999.2

P25 n/aP50 n/aP75 n/a

ROIC-77

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HIND indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001427570
Company name	Vyome Holdings, Inc.
Country	United States
Country code	US
CUSIP number	92943X104
Earnings date	2026-11-13
Earnings time	amc
Employees	18
Enterprise value	$3.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US92943X1046
Last 10-K release date	2026-03-18
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$11.7M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$1.66
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	HIND
U.S. state	Massachusetts
Website	https://www.vyometx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-97.06%
EV/Sales	31.31x
FCF / EV yield	-137.36%
FCF yield	-46.76%
P/B ratio	1.97x
P/S ratio	91.98x
Price / tangible book value	2.08x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	52.74%
Operating margin	-3,250.23%
Pretax margin	-8,926.72%
Profit per employee	$-628,208
Revenue per employee	$7,207
ROA	-48.79%
ROCE	-57.67%
ROE	-999.17%
ROIC	-77.04%
SBC / revenue	5,105.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	4
Gross profit growth	-75.43%
Gross profit growth (Q)	-51.9%
Net income growth years	0
Revenue growth	-67.12%
Revenue growth (Q)	-46.04%
Revenue growth (QoQ)	-14.68%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$10,709
EBIT	$-4.2M
EBITDA	$-4.2M
EPS	$-1.61
FCF per share	$-0.79
Financing cash flow	$13.1M
Free cash flow	$-5.6M
Free cash flow minus SBC	$-12.2M
Gross profit	$68,420
Net cash flow	$7.5M
Net income	$-11.3M
Operating cash flow minus SBC	$-12.2M
Operating income	$-4.2M
Revenue	$129,725
Stock-based compensation	$6.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.76
Book value per share	$0.86
Debt / equity	0
Interest coverage	-101.07
Long-term assets	$1M
Long-term liabilities	$0
Net cash (debt)	$7.9M
Net cash / market cap	65.96%
Net debt / equity	-1.08
Piotroski F-Score	2
Property, plant and equipment	$57,212
Shareholders' equity	$7.3M
Tangible book value	$5.7M
Tangible book value per share	$0.82
Total assets	$9.2M
Total cash	$7.9M
Total debt	$17,310
Total liabilities	$1.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	$8.2M
Current liabilities	$1.9M
Current ratio	4.37
Net working capital	$-1.6M
Quick ratio	4.31
Working capital	$6.3M
Working capital turnover	0.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.12
1D price change	-2.35%
1M price change	-15.69%
1M total return	-15.69%
1W price change	-6.52%
1W total return	-6.52%
1Y price change	-68.84%
1Y return CAGR	-68.87%
1Y total return	-68.84%
20-day SMA	$1.90
200-day SMA	$2.26
3M price change	-14%
3M total return	-14%
50-day SMA	$2.02
50-day SMA vs 200-day SMA	50under200
52-week high	$6.56
52-week high date	2025-11-03
52-week low	$1.62
52-week low date	2026-10-28
6M price change	-20%
6M total return	-20%
All-time high	$16.00
All-time high date	2025-08-15
All-time low	$1.62
All-time low date	2026-10-28
Average true range (ATR)	$0.09
Average volume	9.5K
Beta (1Y)	1.58
Beta (2Y)	1.63
Change from 52-week high	-74.7%
Change from 52-week low	2.47%
Change from all-time high	-89.25%
Change from all-time low	6.17%
Change from open	-1.48%
Day's gap	-0.88%
Dollar volume	$11,881
High price	$1.78
Low price	$1.63
Monthly RSI	20.49
Open price	$1.69
Position in 52-week range	19.59%
Premarket change	0%
Premarket close	$1.70
Premarket price	$1.70
Previous close	$1.70
Price vs 150-day SMA	-18.71%
Price vs 20-day SMA	-9.23%
Price vs 200-day SMA	-23.83%
Price vs 50-day SMA	-14.98%
Relative volume	0.75
RSI	29.97
Sharpe ratio	-1.21
Sortino ratio	-1.66
Volume	7.2K
Weekly RSI	30.97
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.6M
Float percentage	51.95%
Shares change (QoQ)	4.91%
Shares held by insiders	11.2%
Shares held by institutions	6.99%
Shares outstanding	7M
Short % of float	0.72%
Short % of shares	0.37%
Short ratio	1.3 days

Deeper analysis on HIND

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HIND report

Is a complete HIND research report available?

No complete published report is available for Vyome Holdings, Inc. (HIND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vyome Holdings, Inc. (HIND)

Price

Financial snapshot

Fair-value bridge

Latest news · HIND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HIND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HIND

Frequently asked questions